|

Daridorexant 50 mg Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 2Phase 4: 1

Top Sponsors

  • University of Rochester1
  • University Hospital, Montpellier1
  • Douglas Mental Health University Institute1

Indications

  • Alzheimer's Disease3
  • Insomnia Disorder1
  • Postoperative Cognitive Decline1
  • Alzheimer Disease (AD)1
  • Heart Disease1

Other2 trials

Daridorexant for Alzheimer Disease Prevention
Phase 2
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Phase 4

Rochester, New York1 trial

Daridorexant to Prevent Post-cardiotomy Delirium

University of Rochester Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.